Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models.
Buocikova V, Longhin EM, Pilalis E, Mastrokalou C, Miklikova S, Cihova M, Poturnayova A, Mackova K, Babelova A, Trnkova L, El Yamani N, Zheng C, Rios-Mondragon I, Labudova M, Csaderova L, Kuracinova KM, Makovicky P, Kucerova L, Matuskova M, Cimpan MR, Dusinska M, Babal P, Chatziioannou A, Gabelova A, Rundén-Pran E, Smolkova B.
Buocikova V, et al. Among authors: rios mondragon i.
Biomed Pharmacother. 2022 Mar;147:112662. doi: 10.1016/j.biopha.2022.112662. Epub 2022 Jan 25.
Biomed Pharmacother. 2022.
PMID: 35091237
Free article.